Retirement Planning CO Of New England, Inc. Gilead Sciences, Inc. Transaction History
Retirement Planning CO Of New England, Inc.
- $216 Million
- Q2 2025
A detailed history of Retirement Planning CO Of New England, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 11,361 shares of GILD stock, worth $1.36 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
11,361
Previous 11,311
0.44%
Holding current value
$1.36 Million
Previous $1.27 Million
0.63%
% of portfolio
0.58%
Previous 0.67%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
2,298Shares Held
1BCall Options Held
9.42MPut Options Held
9.72M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.14 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.55 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.43 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...